Shariah compliance overview
Not HalalTaysha Gene Therapies, Inc. (TSHA) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS).
Taysha Gene Therapies, Inc. (TSHA) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing securities and assets.
- Business Activity
- 48.56%Limit 5%Fail
- Interest-bearing debt
- 1.99%Limit 30%Pass
- Interest-bearing securities and assets
- 35.10%Limit 30%Fail
- Dividend purification
- 48.56%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Taysha Gene Therapies, Inc. (TSHA). Current Akinda screening label: Not Halal.
